13F-HR filed by Trustees of Columbia University in the City of New York
Trustees of Columbia University in the City of New York filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 8 holding rows worth $655,280,284.
- Accession
- 0000904454-25-000601
- Filer
- CIK 1420995
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 8 entries on the cover page, a total value of $655,280,284 stated on the cover page (in dollars after the unit check, H1), rows summing to $655,280,284 with VALUE read as dollars as filed, 13F file number 028-20933. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 980,596 | $653,253,443 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 47,930 | $617,579 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 291,828 | $472,761 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 133,903 | $265,128 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 9,172 | $236,546 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 4,595 | $223,868 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 249,635 | $210,442 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 33,333 | $517 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-25-000601 | this filing | 2025-11-14 | acceptance time not in the bulk data set |